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TARGETED DISRUPTION OF THE FLT3 LIGAND GENE IN MICE 
AFFECTS MULTIPLE HEMATOPOIETIC LINEAGES, INCLUDING 
NATURAL KILLER CELLS, B LYMPHOCYTES, AND DENDRITIC CELLS. 
H,L McKenna*. R,E._Milkr*. K,„ BrassT, E Jdm skm ky ,* 5LM aliS2Erii*.
B. Pulendran*. D. Lvnch*. MJEsses*. EfiJSsmx*. IJtm iih*, P,E,-Will jams. 
S,D. Lvman*. J„LPeschon*. K, Stocking*- Immunex Corporation, Seattle, 
WA.
Flt3 ligand (flt3L) is a hematopoietic growth factor that has effects on early 
events in the development of a number of btood cell lineages, including B 
lymphocytes and myeloid cells. Flt3L is primarily expressed as a celt membrane 
protein that can give rise to a soluble protein in vivo. We have generated mice 
lacking fU3L using homologous recombination: The resulting f!t3L -/- animals 
are viable but have multiple hematopoietic lineages affected. Total ceilularity in
hematopoietic tissues is reduced compared to strain, age arid sex matched control
i
mice (flt3L +/+); bone marrow ceilularity is 70% of normal, splenocyte numbers 
are 54% of normal, and circulating WBC numbers are 32% of normal. The 
hematocrit levels are unaffected, and blond smears show that the ratio of 
lymphocytes, monocytes and granulocytes is comparable to that of the controls. 
There is a lack of NK 1.1 cells in the spleen, suggesting an absence of natural 
killer cells in the ftt3L -I- mice. Overnight treatment of flt3L 7- mice with poly- 
IC, or rhuIL-I5, or 3 days of treatment with rhuIL-15, did not induce activation of 
NK cells able to lyse YAC targets in vitro* whereas good levels of lytic activity 
were noted in the f!t3L +/+ mice following each of these treatments. Within the 
bone marrow, there is a 5-fold reduction in the number of immature B cells 
(B220+, IgM"), and the number of clonogenic B cell precursors responsive to DL.-7 
or combinations of IL-7 plus flt3L or Steel Factor (SLF) are reduced 15-50-fold. 
However flt3L */- and flt3L +/+ animals immunized with TNP-KLH in alum
I
gave equivalent titers of TNP-specific IgM, IgA and IgG antibodies after both 
primary and secondary challenges, and equivalent numbers of germinal centers 
were noted in the spleen after secondary challenge. Within the spleen of flt3L -/- 
animals the number of CD Ilc+ dendritic cells is reduced to 37% of normal. 
However, on a per cell basis, the dendritic cells are not affected in their ability to
• ' 
stimulate the proliferation of allo-reactive T cells. In summary, mice deficient in
i
f!t3L, though viable, are deficient in splenic NK cells, and have reduced numbers 
of immature B lymphocytes and mature dendritic cells, suggesting an important 
role for flt3L in the development of these three hematopoietic lineages.
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A MUTATION IN THE JAK KINASE JH2 DOMAIN 
HYPERACTIVATES DROSOPHILA AND MAMMALIAN JAK- 
STAT PATHWAYS. H, Luo.* P. Rose,* D.L. Barber.* W.P. 
Hanratty.* S. Lee.» T,M, Roberts.* AD. D'Andrea. 
Dearolf* Developmental Genetics Group, Cancer Biology 
Section, Joint Cancer for Radiation Therapy, Division of 
Cellular and Molecular Biology, Department of Pathology, 
Division of Pediatric Oncology, Dana-Farber Cancer Institute, 
Harvard Medical School, Boston, MA.
The Jak (Janus) family of nonreceptor tyrosine kinases 
plays a critical role in cytokine signal transduction 
pathways. Members of this family Include the mammalian 
Jak kinases and the Drosophila Jak kinase, Hop. The 
dominant HopTum'1 mutation iri the Hop Jak kinase causes 
leukemia-like and other developmental defects in 
Drosophila. We and others have predicted that the Hop7“™'1 
protein is a hyperactive kinase, although this had not been 
proven. In the work described here, we report on the new 
dominant mutation Hop™, which causes abnormalities that 
are similar to but more extreme than Hop7“"1*1. We 
determined that HopT42 contains a glutamic acid to lysine 
substitution at amino acid residue 695 (E695K). This 
residue occurs in the JH2 (kinase-llke) domain, and is 
conserved among all Jak family members. We determined 
that HopTtl[I,‘1i and Hop™ both hyjperphosphorylated and 
hyperactivated the Drosophila Stat protein, D-Stat, when 
overexpressed in Drosophila cells. Moreover, we found that 
the HopT42 phenotype was partially rescued by a reduction of 
wild type D-Stat activity. Finally, generation of the 
corresponding E695K mutation in murine Jak2 resulted in 
increased autophosphorylation and increased activation of 
Stat5 in COS cells. These results demonstrate that the 
mutant Hop proteins do indeed have increased tyrosine 
kinase activity, that the mutations hyperactivate the Hop - 
D-Stat pathway, and that Drosophila is a relevant system for 
the functional dissection of mammalian Jak-Stat pathways. 
Finally, we propose a model for the role of Hop and Hop - D- 
Stat pathway in Drosophila hematopoiesis.
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IDENTIFICATION OF A NEW SIGNAL TRANS­
DUCTION COMPLEX ASSOCIATED WITH C-KIT AND 
ACTIVATED BY STEEL FACTOR. M. Sattler*. G. 
Stuikhande_*._S- Yerma*. E.Pisick*. K. Prasad*. FL Salaia. 
and J.D, Griffin. Dana-Farber Gancer Institute, Boston, M A .'
Steei factor (SF) is a growth and survival factor for 
hematopoietic cells. The receptor for SF, c-kit, contains intrinsic 
tyrosine kinase activity, and binding of SF induces rapid 
tyrosine phosphorylation of several cellular proteins, including 
c-kit Itse f. We found that activation of c-kit induces tyrosine 
phosphorylation of an unusual adapter protein, CRKL, which 
has one SH2 domain and two SH3 domains. Further, CRKL 
coprecipitated with c-kit through an interaction which required 
the CRKL SH3 domains ana not the SH2 domain. A third 
major protein in this complex was identified as the p85 
regulatory subunit of phosphatidylinositoi-3’ kinase (p85PI3K). 
Previous studies have shown that the SH2 domain of 
p85Pl3K binds to c-kit at V719 (murine sequence) after 
receptor activation, and that mutation of this tyrosine causes 
defects in adhesion and induction of early response genes. 
Since p85PI3K contains two proline rich motifs, we asked 
whether the interaction between c-kit and CRKL-SH3 was 
mediated through binding to p85PI3K. Far-Western blotting 
with a CRKL-SH3 GST fusion protein showed that CRKL 
can bind directly to p85PI3K in vitro. However, although 
CRKL was pre-associated with p85PI3K, the interaction was 
increased after SF stimulation, suggesting that the interactions 
of these 3 proteins are complex. Since the binding of CRKL 
to this complex is mediated by SH3 interactions, the CRKL- 
SH2 domain is available to recruit other signaling proteins, 
such as p120CBL, into the complex. We conclude that the 
signaling pathway of c-kit involving PI3K involves CRKL and 
predict that CRKL will recruit additional signaling molecules into 
this complex. Signaling molecules recruited by CRKL may 
well be involved in propagating signals involving PI3K such 
as viability and adhesion.
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ANTI-LFA-1 BLOCKING ANTIBODIES PREVENT MOBILIZATION 
OF HEMATOPOIETIC PROGENITOR CELLS INDUCED BY INTER­
LEUKIN-8. J.F.M. Pruiit/ C.G. Figdor.* Y. van Koovk.* R. Willemze and 
W.E. Fibhe. Lab of Exp Hematology, Dept of Hematology, Univ Hospital 
Leiden, Dept of Tumor Immunology, Univ Hospital Nijmegen, The Nether­
lands.
Previously, we have demonstrated that Interleukln-8 (IL-8) induces rapid 
(15-30 minutes) mobilization of hematopoietic progenitor cells (HPC) with 
colony forming, radioprotective and lympho-myeloid repopulating ability 
(Blood 85: 2269, 1995). Since flr  and fla-integrins are essential for adhesion 
and transendothelial migration of HPC, we studied the involvement of LFA-1 
in IL-8-induced mobilization. Baib/c mice (age 8-12 weeks, weight 20-25 
gram) were treated with ah intraperitoneal injection (i.p.) of 100 fxg anti- 
LFA-1 (H154.163). Following a single injection of anti-LFA-1, no mobiliza­
tion of colony forming cells (CFU-GM) was observed within 24 hours. These 
mice showed a consistent thrombocytopenia (anti-LFA-1 296 ± 65, saline 
749 ± U5xlGP/ml, mean ± SD, p < 0.01); no effect on the white blood cell 
count was observed. Mice were then pretreated with 100/jg of anti-LFA-i or 
saline and subsequently injected with 30 ptg of IL-8 i.p., administered 20 
min. prior to harvesting peripheral blood. Pretreatment with antl-LFA-l 
completely prevented IL-8-induced mobilization of HPC (anti-LFA-1 + IL-8 
42 ± 28, n = 18 v. saline + IL-8 590 ± 771 CFU-GM/ml blood, n=17; 
mean ± SD, p < 0.001). In contrast, anti-LFA-1 pretreatment did not 
influence IL-i (1 /*g i.p. at -360 min.) induced mobilization of HPC (anti-
LFA-1 + IL-1 679, saline + IL-i 600 CFU-GM/ml blood, mean, n=2).
• i
Addition of anti-LFA-1 antibodies to colony cultures in semisolid medium 
had no inhibitory activity. Since LFA-1 is reported to be expressed on more 
differentiated HPC, it was considered that the IL-8-induced mobilization of 
more primitive HPC was not blocked by anti-LFA-1. Transplantation of 
5xl03 blood-derived mononuclear cells (MNC) from IL-8 mobilized animals 
pretreated with anti-LFA-1 or saline controls protected 25 and 19% of 
lethally irradiated recipient mice respectively. In contrast, the survival of 
recipients transplanted with (5xl0!) MNC derived from IL-8 mobilized 
animals was 86% (n=20 per group in two experiments, p<0.01). We 
conclude that anti-LFA-1 antibodies completely prevent the rapid mobilization 
of colony forming cells and cells with radioprotective capacity induced by 1L-
8. These results indicate a major role for the fl2-integrin LFA-1 in the IL-8 
induced-mobiiization of HPC.
